market industry reports

Next Generation Sequencing Market by Product & Services, Technology, Application & Region- Global Analysis & Forecast 2019-2030:Eurofins Scientific, Pacific Biosciences O

According to the new market research report “Next generation sequencing (NGS) Market by Product & Services (Pre-Sequencing Products & Service, Sequencing Services, Data Analysis, Storage, and Management), Technology (Sequencing By Synthesis Ion Semiconductor Sequencing, Single-Molecule Real-Time Sequencing), Application (Diagnostics, Drug Discovery), End User (Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Academic Institutes & Research Centers) - Global Analysis & Forecast 2019-2030”, published by Market Industry Reports, the global wearable injectors market is estimated to be over US$ 4.5 Bn in 2017. It is anticipated to grow at a double digit CAGR from 2019 to 2030.


New York, NY -- (SBWIRE) -- 03/03/2019 -- The Study On Major Key Players in the Next generation sequencing (NGS) Market are Agilent Technologies, 10x Genomics, Beckman Coulter (A Subsidiary of Danaher), Becton, Dickinson and Company, Eurofins Scientific, Pacific Biosciences of California, Inc., BGI, Illumina, Inc., F. Hoffmann-La Roche AG, among others.

The market for next generation sequencing can be segmented based on product & services, technology, application, end-users and geography. The product segment can be categorized as Pre-Sequencing Products & Services, NGS Consumables, Platforms, & Services for Platforms, Sequencing Services and NGS Data Analysis, Storage, and Management (Bioinformatics). On the basis of technology the market is subdivided into sequencing by synthesis, ion semiconductor sequencing, single molecule real time sequencing, Nanopore Sequencing, and Other Sequencing Technologies.

Download free PDF sample of the report from the official link-

Increasing Demand of NGS for Clinical Application

The advent of NGS has led to significant changes in the scientific approach utilized for both clinical and research applications. Both RNA & DNA sequencing have been proven to be extremely useful for studying evolutionary relationships, mutation, sequence variation and other vital information associated with genes. The clinical applications of which has been pivotal in diagnosing germline diseases and understanding the genetic basis of various hereditary or chronic diseases among others. The growing incidences of several clinical ailments has directly contributed to the extensive adoption of NGS and other sequencing techniques, to obtain better understanding of the diseases and formulate necessary therapies for the same.

Application of NGS in Oncology

Improvement in the overall NGS technology in terms of pipeline analyses, sequencing chemistry, data interpretation, reliability and costs has led to application of the technique in several fields of medical sciences, including oncology. The utilization of NGS technologies provides accurate and deeper knowledge regarding molecular basis of individual tumors, thereby providing a better, efficient and long lasting treatment option. According to Cancer Research UK, the number of cancer cases reported worldwide in the year 2018, was approximately around 17 million. It is further projected that within the period 2018-2040, the total incidence rate of worldwide cancer will increment by 62%. The growing incidences of cancer are anticipated to present a lucrative growth opportunity for the global Next generation sequencing (NGS) market in the coming years.

Budget Constraints among Developing Economies to Restrain the Market

Although costs associated with sequencing of genetic data has come down significantly in recent times. Yet, the current costs for sequencing genomes is one of the major factors affecting the growth of the Next generation sequencing (NGS) usage among end-users from developing economies. Thereby, price related concerns is anticipated to be limiting the use of NGS technologies and restraining the extensive growth of the market during the forecast period.

View Full Report Details and Table of Contents-

Key points from TOC


(Business Overview, Products/Services Offered, Financial Performance, R&D Intensity, Marketing & Sales Intensity, Recent Developments, Analyst Corner)*
12.1   10x Genomics
12.2   Agilent Technologies, Inc.
12.3   Beckman Coulter (A Subsidiary of Danaher)
12.4   Becton, Dickinson and Company
12.5   BGI
12.6   Eurofins Scientific
12.7   F. Hoffmann-La Roche AG
12.8   Genewiz
12.9   Illumina, Inc.
12.10     Macrogen, Inc


This Next generation sequencing (NGS) market report holds answers to some important questions like:

- What is the size of occupied by the prominent leaders for the forecast period, 2019 to 2030? What will be the share and the growth rate of theNext generation sequencing (NGS) market during the forecast period?
- What are the future prospects for theNext generation sequencing (NGS) industry in the coming years?
- Which trends are likely to contribute to the development rate of the industry during the forecast period, 2019 to 2030?
- What are the future prospects of theNext generation sequencing (NGS) industry for the forecast period, 2019 to 2030?
- Which countries are expected to grow at the fastest rate?
- Which factors have attributed to an increased sale worldwide?
- What is the present status of competitive development?

Ask For Inquiry before Buying @

About Market Industry Reports
Market Industry Reports is a global leader in market measurement & advisory services, Market Industry Reports is at the forefront of innovation to address the worldwide industry trends and opportunities. We identified the caliber of market dynamics & hence we excel in the areas of innovation and optimization, integrity, curiosity, customer and brand experience, and strategic business intelligence through our research.

We continue to pioneer state-of-the-art approach in research & analysis that makes complex world simpler to stay ahead of the curve. By nurturing the perception of genius and optimized market intelligence we bring proficient contingency to our clients in the evolving world of technologies, megatrends and industry convergence. We empower and inspire Vanguards to fuel and shape their business to build and grow world-class consumer products.

Contact Us- 

502, Sai Radhe, Kennedy Road,
Behind Hotel Sheraton Grand,
Near Pune Station, Pune 411 001
Phone: + 91 8956 767 535
Follow Us- LinkedIn | Twitter | Google+ | Facebook